// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Long-term Outcomes in Women and Men Following Percutaneous Coronary Intervention: An individual patient data pooled analysis from 21 randomized trials

Ioanna Kosmidou - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

The routine use of an iso-osmolar contrast medium and the occurrence of acute kidney injury following percutaneous coronary intervention for ST elevation myocardial infarction

Diluka Premawardhana - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Myocardial infarction

N/A

Five-Year Clinical Outcomes for Resolute Zotarolimus-Eluting Stents in Total Occlusions

Robert Yeh - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Myocardial infarction

ZoMaxx

An international analyses of 122,610 NSTEMI patients with 5 year outcomes: assessing the influence of age and comorbidities on invasively vs medically managed patients between 2004 and 2014.

Majd Protty - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Grace

Reducing the need for invasive pressure wire assessment in patients using a novel angiographic scoring tool

Michael Michail - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Diagnostic Accuracy of iFR Versus FFR in the Left Versus Right Coronary Artery

Ankita Gore - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Post-implantation Strut Protrusion and Neointimal Thickness at follow-up in Absorn Bioresorbable Scaffold: A serial Shear Stress Analysis Up to Five Years

Erhan Tenekecioglu - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Endothelial Shear Stress and Local Viscosity Assessment of Coronary Bioresorbable Scaffold: A Five-Year Follow Up

Erhan Tenekecioglu - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Predictors of Target Lesion Revascularization After Implantation of Second-Generation Drug-Eluting Stents in Randomized Trials and the “Real-World”: Analysis From Two Large Datasets

Behnood Bikdeli - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Impact of rate of recruitment on all-cause mortality: Insights from the GLOBAL LEADERS all-comers trial

Kuniaki Takahashi - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Angina

N/A

Glasgow Rotational Atherectomy Efficiency (GRACE) study: Safety of a Minimalist Approach

Tom Ford - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Grace

Extending Application of Intravascular Lithotripsy to a High Risk Real World Population

Julian Yeoh - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Impact of post-procedural minimal stent area by IVUS on 2-year outcome after PCI in the SYNTAX II trial.

Yuki Katagiri - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic total occlusion

N/A

The Effect of Plaque Type on Strut Embedment/Protrusion and Shear Stress in Bioresorbable Scaffold: Is There a New Horizon For Bioresorbable Scaffolds?

Erhan Tenekecioglu - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Biodegradable versus polymer-free drug-eluting stents for the treatment of coronary artery disease: a meta-analysis of randomized controlled trials

Jason Nogic - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Coronary Artery Disease

N/A

Discharge Antithrombotic Medication and Clinical Events Through 1 Year in the Global Amulet Observational Study

David Hildick-Smith - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Left atrial appendage occlusion

Clopidogrel bisulfate

Technical Success of Acute Stroke Interventions Performed by Cardiologists – Single Center Experience

Marius Hornung - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

N/A

Comparing 3 year outcomes between medical therapy and percutaneous revascularisation for the surgically ineligible cohort.

Avedis Ekmejian - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Myocardial infarction

N/A

Prospective randomized comparison of paclitaxel-coated balloon versus bare-metal stent in high bleeding risk patients with de novo native coronary artery lesions

Eun-Seok Shin - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Coronary artery lesions

Paclitaxel

Influence of Valve Type on Thrombocytopenia Following Transcatheter Aortic Valve Implantation (TAVI)

Sally Hickman - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Thrombocytopenia

N/A

Copyright © 2026. QuantiNova All rights reserved